A team at Weill Cornell Medicine has mapped the location and spatial features of blood-forming cells within human bone marrow, confirming hypotheses about the anatomy of this tissue and providing a powerful new means to study diseases that affect bone marrow.
In patients with severe artery blockage in the lower leg, an artery-supporting device called a resorbable scaffold is superior to angioplasty, according to the results of a large international clinical trial co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Steps from where dozens of young immigrant Jewish and Italian women died when a fire erupted in the locked sweatshop, 60 Cornell students, faculty, staff and alumni gathered Oct. 11 to honor the legacy of the Triangle Shirtwaist Factory tragedy.
A drug currently in clinical trials as a cancer therapy can also stimulate pancreatic beta cells to secrete insulin, revealing a previously unknown mechanism for insulin regulation in Type 2 diabetes, according to a new study by Weill Cornell Medicine investigators.
Researchers at Weill Cornell Medicine have uncovered a novel route to stimulate the growth of healthy insulin-producing pancreatic beta cells in a preclinical model of diabetes. The findings hold promise for future therapeutics that will improve the lives of individuals with Type 2 diabetes – a condition that affects more than 500 million people worldwide.
Researchers at Weill Cornell Medicine have demonstrated how amyloid beta, a peptide associated with Alzheimer’s disease, can interact with a protein receptor on immune cells in the brain. This triggers a reaction that damages blood vessels and causes neurodegeneration.
U.S. Secretary of Transportation Pete Buttigieg provided an intimate look at the most pressing issues in federal infrastructure planning during a conversation on November 2 with students and faculty members from the Cornell Jeb E. Brooks School of Public Policy and the Roosevelt House Public Policy Institute at Hunter College.